Clinical trial
Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a…
NCT00100633 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00100633 |
|---|---|
| Title | Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People |
| Official title | Immunologic Effects of CpG ODN Administration to HIV Uninfected and HIV Infected Patients |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Hepatitis B |
| Intervention type | Biological, Drug |
| Interventions | CpG7909 oligodeoxynucleotides (ODN), Hepatitis B virus vaccine |
| Enrollment | 30 |
| Start date | Dec 1, 2004 |
| Primary completion | Feb 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jan 5, 2005 |
| Last update posted | Oct 1, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: